Ask the Expert with Dana-Farber Cancer Institute’s Dr. Jackman CancerConnect recently partnered with Dana-Farber Cancer Institute to provide you with […]
Precision medicine continues to impact the lives of lung cancer patients with research into genomics and genetics leading to unprecedented […]
Today, September 6, the 16th World Conference on Lung Cancer (WCLC) begins in Denver, Colorado. The WCLC is the world’s […]
The cancer research community is moving forward in its efforts find more effective treatment for patients with lung cancer. Current […]
November 7, 2014 Sun Valley, ID & Fort Worth, TX—OMNI Health Media (OMNI) announces the launch of lung cancer programs […]
Radiation to the brain prior to detectable spread of cancer to the brain improved survival in patients with both early- […]
Among people diagnosed with nonmetastatic lung or colorectal cancer, the majority return to work, according to a study recently published […]
Quitting smoking after a diagnosis of early-stage lung cancer may reduce the risk of cancer recurrence and death. These results were published in the British Medical Journal.
As the month of November brings lung cancer into focus, it’s time to increase public understanding of the disease, including its prevalence, approaches to screening and prevention, treatment options, and resources that offer updated lung cancer information throughout the year.
Treatment with a combination of thalidomide and chemotherapy did not improve survival among patients with small cell lung cancer, and resulted in a higher risk of blood clots than treatment with chemotherapy alone. The results of this study were published in the Journal of the National Cancer Institute.
Non-Platinum Chemotherapy as Effective for SCLC Chemotherapy regimens that do not contain platinum agents (Platinol and Paraplatin) appear to be just as effective as regimens that do contain platinum agents in the treatment of small cell lung cancer. These results were recently published in the Cochrane Database of Systematic Reviews. Small cell lung cancer (SCLC) accounts for approximately one-quarter of all lung cancers.
Increasing the dose intensity of chemotherapy does not appear to improve survival in small cell lung cancer. These results were […]
PET Scans May Help Identify Early Lung Cancer According to an article recently published in the Journal of the National […]
Advances in the Management of Small-Cell Lung Cancer: Highlights from the 12th World Conference on Lung Cancer Introduction Approximately 25,000 […]
Possible Benefit of Surgery in Patients with Very Limited Small Cell Lung Cancer According to the results of a study […]
Dose-intensive Chemotherapy Improves Survival for Patients with Small Cell Lung Cancer According to an article recently published in the Journal […]
Chemotherapy and Twice-daily Radiation Therapy Promising for Small Cell Lung Cancer According to an article recently published in the Journal […]
Early Radiation Therapy May Not Improve Survival in Limited Small-Cell Lung Cancer According to an article recently published in the […]